Alec Visit 1: A 62-year-old man presenting with low back pain

Title:

Alec Visit 1: A 62-year-old man presenting with low back pain

Topic: Hematology-Oncology
Relevant Terms: Multiple Myeloma
Primary Audience: Hematologists/Oncologists
Launch Date: 29-Nov-12
Credits: AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Clinical Decision Points in Multiple Myeloma

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Use cytogenetics, fluorescence in situ hybridization (FISH), and gene expression profiling to define patient prognosis and risk stratification
  2. Implement evidence-based strategies to prolong the duration of response in patients with multiple myeloma
  3. Incorporate current consensus recommendations, guidelines, and the latest clinical evidence in the management of multiple myeloma

    Faculty

    Paul G. Richardson, MD
    RJ Corman Associate Professor of Medicine
    Harvard Medical School
    Clinical Director, Jerome Lipper Center for Multiple Myeloma
    Dana-Farber Cancer Institute
    Boston, Massachusetts
    Philip L. McCarthy, MD
    Blood and Marrow Transplant Program
    Department of Medicine
    Roswell Park Cancer Institute Corporation
    Buffalo, New York
    Peter Voorhees, MD
    Associate Professor
    Hematology-Oncology
    UNC Lineberger Comprehensive Cancer Center
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina
    Clinical Decision Points in Multiple Myeloma
     
    Release date: November 29, 2012
    Expiration date: November 29, 2013
    Estimated time to complete activity: 1 hours
     
    Sponsored by Curatio CME Institute
     
     
    Support for this activity has been provided through educational grants from Celgene and Millennium: The Takeda Oncology Company.
     
    Target Audience
    This activity has been designed to meet the educational needs of hematologist-oncologists, oncologists, and other health care providers involved in the care of patients with multiple myeloma.
     
    Accreditation Statement
    Curatio CME Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
     
    Credit Designation
    Curatio CME Institute designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
     
    Method of Participation
    There are no fees for participating in this CME activity. To receive credit during the period November 29, 2012 to November 29, 2013, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, (3) complete the posttest and activity evaluation form, including the certificate information section.
     
    To obtain a certificate, participants must receive a score of 70% or better on the posttest. The posttest can be accessed at the end of the activity. Please e-mail any questions to cmeinfo@curatiocme.com.
     
    Medium
    The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.
     
    Disclaimer
    The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient's medical condition.
     
    Course Viewing Requirements
    To view the activity online you will need the following hardware/software: Personal computer or smartphone with Internet access, a Web browser (Google Chrome, Internet Explorer v7.0+, Firefox v3.5+, Safari v4.0+, or Mozilla v1.4+) with JavaScript enabled.

    Disclosure
    In accordance with the ACCME Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:
     
    Paul G. Richardson, MD, has disclosed the following relevant financial relationships:
    Advisory Board:  Bristol-Myers Squibb, Celgene, Johnson & Johnson, Keryx, Millennium, Nereus, Novartis
    Dr. Richardson discusses the unlabeled or investigational use of a commercial product.
    Philip L. McCarthy, MD, has disclosed the following relevant financial relationship:
    Speaker: Celgene; Consultant: Celgene
    Dr. McCarthy discusses the unlabeled or investigational use of a commercial product.
    Peter Voorhees, MD, has disclosed the following relevant financial relationships: 
    Consultant: Abbott Laboratories, Celgene, MedImmune
    Advisory Board: Abbott Laboratories, Celgene, MedImmune
    Research Support: Acetylon Pharmaceuticals, Inc., Celgene, GlaxoSmithKline, Janssen, Merck, Prolexys
     
    Curatio CME Institute
    Denise C. LaTemple, PhD, President, has disclosed no relevant financial relationships.
    Jonathan S. Simmons, ELS, Senior Managing Editor, has disclosed no relevant financial relationships.
     
    Unapproved Product Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute, Celgene, and Millennium: The Takeda Oncology Company do not recommend the use of any agent outside the labeled indications.
     
    The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute, Celgene, or Millennium: The Takeda Oncology Company. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
     
    Policy on Privacy and Confidentiality
    Curatio CME Institute collects the information provided by the user. The information is used to notify users about upcoming programs and educational information that may be of interest. The information is not shared or used for commercial purposes unless prior permission has been granted by the user.
     
    Curatio CME Institute may collect standard Web traffic data such as time and date of visit. Curatio CME Institute uses this information to administer its Web site. Browsing activity is recorded to form aggregate and anonymous demographic information, which is used as described above. Curatio CME Institute does not sell or offer to sell any user data, including registration and billing information, to any third parties for commercial purposes. Curatio CME Institute does, when required, provide the minimum subset of information to third parties that are responsible for accreditation of and issuance of certification for CME/CE tests. By participating in the Web-based activity, the user agrees that Curatio CME Institute has full permission to provide this minimum subset of information to the third parties as required by law.